Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma
Titel:
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma
Auteur:
Mahalingam, Devalingam Malik, Laeeq Beeram, Muralidhar Rodon, Jordi Sankhala, Kamalesh Mita, Alain Benjamin, Daniel Ketchum, Norma Michalek, Joel Tolcher, Anthony Wright, John Sarantopoulos, John